Pharmacologic Treatment of IPF
Sign Up to like & getrecommendations! Published in 2018 at "Respiratory Medicine"
DOI: 10.1007/978-3-319-99975-3_13
Abstract: The pathogenetic mechanisms leading to lung fibrosis in idiopathic pulmonary fibrosis (IPF) are mostly unknown. The old paradigm of inflammation has been substantially replaced by hypotheses of dysregulated wound healing with an excessive production of… read more here.
Keywords: guideline; pharmacologic treatment; treatment; treatment ipf ... See more keywords
Immunologic responses to antifibrotic treatment in IPF patients.
Sign Up to like & getrecommendations! Published in 2021 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2021.107525
Abstract: BACKGROUND Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease limited to the lungs. Immunological dysregulation may significantly participate in the pathophysiology of IPF. The immunological responses to nintedanib therapy in IPF patients… read more here.
Keywords: antifibrotic treatment; treatment ipf; cell percentages; ipf patients ... See more keywords
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Emerging Drugs"
DOI: 10.1080/14728214.2018.1471465
Abstract: ABSTRACT Introduction: Idiopathic pulmonary fibrosis is a chronic, progressive fibrotic lung disease of unknown etiology associated with a high morbidity and mortality. The hallmark of the disease is impaired healing after alveolar epithelial injury in… read more here.
Keywords: fibrosis; idiopathic pulmonary; emerging drugs; treatment ... See more keywords